BUGIANESI, Elisabetta

BUGIANESI, Elisabetta  

SCIENZE MEDICHE  

Mostra records
Risultati 1 - 20 di 397 (tempo di esecuzione: 0.026 secondi).
Titolo Data di pubblicazione Autore(i) File
A comparative study between ultrasound evaluation, liver stiffness measurement and biopsy for staging of hepatic fibrosis in patients with chronic liver disease 2009 S. Gaia; C. Cocuzza; E. Rolle; E. Bugianesi; P. Carucci; E. Vanni; A. Evangelista; M. Rizzetto; F. Brunello
A new mutation of the apolipoprotein B gene originates the apo B32,4 truncated protein. 2002 Guardamagna O; Bugianesi E; Bonardi R; Molini V; Bondone C; Bobbio A;
A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease 2005 E. Bugianesi;E. Gentilcore;R. Manini;S. Natale;E. Vanni;N. Villanova;E. David;M. Rizzetto;G.Marchesini
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease 2005 E. BUGIANESI; E. GENTILCORE; R. MANINI; S. NATALE; E. VANNI; N. VILLANOVA; E. DAVID; M. RIZZETTO; G. MARCHESINI
A randomized controlled trial of metformin vs. vitamin E or prescriptive diet in Non Alcoholic Fatty Liver Disease 2005 E. Vanni; E. Bugianesi; G. Marchesini; E. Gentilcore; R. Marzocchi; M. Rizzetto
A randomized controlled trial of metformin vs. vitamin E or prescriptive diet in Non Alcoholic Fatty Liver Disease 2005 E. Vanni; E. Bugianesi; G. Marchesini; E. Gentilcore; R. Marzocchi; M. Rizzetto
A web-based program for implementing lifestyle changing towards healthy diet and habitual physical activity in NAFLD 2014 A. Mazzotti; E. Bugianesi; S. Bellentani; A. Barchetti; E. Vanni; R. Marzocchi; G. Marchesini
Abnormal insulin sensitivity in-chronic hepatitis C virus (HCV) infection: A link with steatosis? 2002 Bugianesi E; Vanni E; Gastaldelli A; Abate ML; Hickman I; Gambino R; Cassader M; Smedile A; Ferrannini E; Rizzetto M
Absolute quantification of intrahepatic HBV covalently-closed-circular DNA by droplet digital PCR 2017 Gian Paolo Caviglia; Maria Lorena Abate; Antonella Olivero; Chiara Rosso; Alessia Ciancio; Elisabetta Bugianesi; Giorgio Maria Saracco; Antonina Smedile
Absolute quantification of intrahepatic hepatitis B virus covalently-closed-circular DNA by droplet digital PCR technology 2017 Caviglia, G.P.; Abate, M.L.; Olivero, A.; Rosso, C.; Ciancio, A.; Bugianesi, E.; Saracco, G.M.; Smedile, A.
Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease 2019 Ribaldone, Davide Giuseppe; Caviglia, Gian Paolo; Abdulle, Amina; Pellicano, Rinaldo; Ditto, Maria Chiara; Morino, Mario; Fusaro, Enrico; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Astegiano, Marco
Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease 2009 Milner KL; van der Poorten D; Xu A; Bugianesi E; Kench JG; Lam KS; Chisholm DJ; George J.
Adiponectin isoforms, insulin resistance and liver histology in nonalcoholic fatty liver disease. 2011 Bianchi G; Bugianesi E; Frystyk J; Tarnow L; Flyvbjerg A; Marchesini G.
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals 2022 Saponaro, Chiara; Sabatini, Silvia; Gaggini, Melania; Carli, Fabrizia; Rosso, Chiara; Positano, Vincenzo; Armandi, Angelo; Caviglia, Gian Paolo; Faletti, Riccardo; Bugianesi, Elisabetta; Gastaldelli, Amalia
Adipose tissue insulin resistance and inflammation, but not reduced hepatic fat oxidation, are associated to active NASH and severe fibrosis. 2020 Amalia Gastaldelli, Melania Gaggini, Michael Allison, Ramy Younes, Chiara Rosso, Jorn M. Schattenberg, Vlad Ratziu, Elisabetta Bugianesi, Quentin Anstee
Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease 2016 Marietti, M.; Rosso, C.; Gaggini, M.; Saponaro, C.; Kazankov, K.; Buzzigoli, E.; Holler, H.J.; Caviglia, G.P.; Abate, M.L.; Smedile, A.; Saracco, G.M.; Vilstrup, H.; George, J.; Gronbaek, H.; Gastaldelli, A.; Bugianesi, E.
Advancing the global public health agenda for NAFLD: a consensus statement 2022 Lazarus J.V.; Mark H.E.; Anstee Q.M.; Arab J.P.; Batterham R.L.; Castera L.; Cortez-Pinto H.; Crespo J.; Cusi K.; Dirac M.A.; Francque S.; George J.; Hagstrom H.; Huang T.T.-K.; Ismail M.H.; Kautz A.; Sarin S.K.; Loomba R.; Miller V.; Newsome P.N.; Ninburg M.; Ocama P.; Ratziu V.; Rinella M.; Romero D.; Romero-Gomez M.; Schattenberg J.M.; Tsochatzis E.A.; Valenti L.; Wong V.W.-S.; Yilmaz Y.; Younossi Z.M.; Zelber-Sagi S.; Aberg F.; Adams L.; Khatry M.S.A.; Naamani K.A.; Murillo O.A.; Allen A.M.; Alnaser F.; Alqahtani S.A.; Alswat K.; Alvaro D.; Andrade R.J.; Arrese M.; Awuku Y.A.; Ayesha M.; Baatarkhuu O.; Bakieva S.; Basu R.; Bataller R.; Bedri S.; Bosi E.; Bourliere M.; Bruha R.; Bugianesi E.; Burra P.; Buti M.; Byrne C.D.; Calleja J.L.; Carrieri P.; Carter F.; Fernandez M.I.C.; Castillo-Lopez G.; Castro-Narro G.E.; Chan H.L.Y.; Chan W.-K.; Chang Y.; Colombo M.; Coppell K.J.; Corey K.; Craxi A.; Cryer D.; Dassanayake A.; Martins A.A.S.; de Ledinghen V.; DelPrato S.; Demaio A.; Desalegn H.; Dillon J.; Duseja A.; Dorairaj P.; Ekstedt M.; El Kassas M.; Elsanousi O.M.; Esmat G.; Fan J.-G.; Farpour-Lambert N.; Flisiak R.; Fouad Y.; Fuchs M.; Gani R.A.; Gerber L.; Ghazinyan H.; Gheorghe L.; Goh G.B.-B.; Gronbaek H.; Gulnara A.; Hamid S.; Hebditch V.; Hickman I.J.; Hocking S.L.; Hunyady B.; Idilman R.; Isakov V.A.; Jamal M.H.; Jepsen P.; Iskandar N.J.; Song M.J.; Sudhamshu K.C.; Kakizaki S.; Kalamitsis G.; Kanwal F.; Kao J.-H.; Kaplan L.; Kawaguchi T.; Khader Y.; Kim S.U.; Kodjoh N.; Koek G.; Koike K.; Komas N.P.; Korenjak M.; Kugelmas M.; Labidi A.; Lange N.F.; Lavine J.E.; Lazo M.; Lee N.; Lesmana C.R.A.; Liu C.-J.; Long M.T.; Lopez-Jaramillo P.; Malekzadeh R.; Mahtab M.A.; Marchesini G.; Marinho R.; Vazquez S.E.M.; Mateva L.; Nlombi C.M.; Melin P.; Mikolasevic I.; Milovanovic T.; Musso C.; Nakajima A.; Nava E.; Nersesov A.V.; Nikolova D.; Norris S.; Novak K.; Oben J.; Ong J.P.; Onyekwere C.; Papatheodoridis G.; Paruk I.; Patel K.; Macedo M.P.; Penha-Goncalves C.; Figueroa M.P.; Hofmann W.P.; Petta S.; de Oliveira C.P.M.S.; Puri P.; Pan C.Q.; Rac M.; Ralston J.; Ramji A.; Razavi H.; Alvares-da-Silva M.R.; Roberts S.; Roden M.; Rose T.; Rouabhia S.; Rovere-Querini P.; Rowe I.A.; Sadirova S.; Salupere R.; Saparbu T.; Sayegh R.; Sebastiani G.; Seki Y.; Selmo J.; Serme A.K.; Shaw J.E.; Shenoy T.; Sheron N.; Shibolet O.; Silva M.; Skrypnyk I.; Socha P.; Soriano J.; Spearman C.W.; Sridharan K.; Suarez J.J.; Sheriff D.S.; Sung K.-C.; Swain M.; Tacke F.; Taheri S.; Tan S.-S.; Tapper E.B.; Yki-Jarvinen H.; Thiele M.; Shawa I.T.; Tolmane I.; Torres E.A.; Trauner M.; Treeprasertsuk S.; Turcanu A.; Valantinas J.; Vesterhus M.; Waked I.; Wild S.H.; Willemse J.; Wong R.J.; Xanthakos S.; Young D.Y.; Yu M.-L.; Zheng K.I.; Zeybel M.; Zheng M.-H.
Adverse impact of visceral fat on lipid and metabolic profile in fatty liver disease 2015 Saponaro, C; Gaggini, M; Rosso, C; Buzzigoli, E; Carli, F; Ciociaro, D; Mezzabotta, L; Vanni, E; Saba, F; Abate, M; Smedile, A; Rizzetto, M; Bugianesi, E; Gastaldelli, A
After oral fat load NAFLD subjects and healthy controls show different serum free fatty acid trends. 2014 R. Gambino; E. Bugianesi; C. Rosso; L. Mezzabotta; S. Pinach; N. Alemanno; F. Saba; M. Cassader
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis 2016 Mcpherson, Stuart; Hardy, Tim; Dufour, Jean Francois; Petta, Salvatore; Romero Gomez, Manuel; Allison, Mike; Oliveira, Claudia P; Francque, Sven; van Gaal, Luc; Schattenberg, Jörn M; Tiniakos, Dina; Burt, Alastair; Bugianesi, Elisabetta; Ratziu, Vlad; Day, Christopher P; Anstee, Quentin M.